Navigation Links
Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
Date:1/8/2010

EAST BRUNSWICK, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.

The Company announced that:

  • It has completed the reversion to the manufacturing processes used to manufacture its pegloticase active pharmaceutical ingredient (API) drug substance for the pivotal Phase 3 clinical trials which the Company had committed to pursue during the September 2009 Type "A" meeting as its plan to address the concerns raised by the Food and Drug Administration (FDA) in the July 31, 2009 complete response letter. Three consecutive batches of pegloticase API drug substance were manufactured in late October 2009 at the Company's third party contract manufacturer (CMO) and were then manufactured into final KRYSTEXXA drug product in November 2009. All batches were placed on stability testing by early December 2009. This manufacturing process reversion included the successful return to the PEGylation concentration utilized in the manufacture of pegloticase API for the pivotal replicate Phase 3 clinical trials.
  • The Company has received from its third party testing laboratories the majority of the in-process and final release analytical test results performed on the three consecutive batches of pegloticase API drug substance and final drug product. These analytical tests are necessary to validate these batches as being comparable to the drug product used in the Phase 3 clinical trials to establish the safety and effic
    '/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
2. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
3. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
4. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
5. Savient Provides Update on Pegloticase BLA
6. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
7. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
8. New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
9. Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc.
10. New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
11. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  Novastem, a leader in regenerative ... in its study for ischemic stroke at Clinica ... ischemic strokes account for 87 percent of all ... in the study, entitled "Internal Research Protocol in ... Stem Cells and Intrathecal Administration of Neural Stem ...
(Date:12/24/2014)... , Dec. 24, 2014  Commonwealth Cornerstone Group (CCG) ... Tax Credits transaction on Tuesday to help fund the expansion ... (PHN) in Sharon . ... Pennsylvania . It is the largest employer ... more than 150 people on staff. Currently, PHN ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
... -- Golden Meditech Holdings Limited ("Golden Meditech", ... 910801.TW), which embodies a leading medical devices enterprise, a major ... cord blood banking operator in China, is pleased to announce ... With a track record in China for establishing the ...
... THE WOODLANDS, Texas, Sept. 6, 2011 Lexicon ... biopharmaceutical company focused on discovering breakthrough treatments for human ... Ph.D. , Lexicon,s president and chief executive officer, will ... New York City on Wednesday, September 14, 2011 at ...
Cached Medicine Technology:Golden Meditech Celebrates Grand Opening of Taiwan Representative Office 2Golden Meditech Celebrates Grand Opening of Taiwan Representative Office 3Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference 2
(Date:12/25/2014)... When head lice hits a home or ... to get rid of it while keeping it from taking ... now have the solution right in their neighborhood: Lice ... Troopers provides full spectrum head lice screening and treatment services ... Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- Overeating is common during ... eat in moderation, an expert says. "Don,t arrive at ... calories if you know you,ll be attending a party, but ... Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount Kisco, ... to eat healthy during the day and even to have ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number ... Southern District of West Virginia, Bernstein Liebhard LLP reports. ... the Court is scheduled to convene a Joint Status ... 2015, at 10:00 a.m. Parties have been directed to ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Each year ... and 2 million hospital admissions across the nation (according ... ). The CDC’s National Hospital Ambulatory Medical Care ... a survey conducted in 2010. They estimated that there ... that resulted in a primary diagnosis of broken bone ...
(Date:12/24/2014)... Epigenetics finds applications in a large number of fields ... biology, and research for metabolic and genetic disorders. It ... used techniques for the discovery and development of cancer ... rapidly growing worldwide. In 2012, there were 14.1 million ... million people living with cancer (within five years of ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3
... are taking place at more than 1,100 facilities across ... A free online service that provides clinical trial information ... was launched this week by the University of California, ... , BreastCancerTrials.org includes information about clinical trials taking place ...
... 6 When a loved one is ... Life-Prints stores and,protects life-saving information inside a ... encryption, Life-Prints was developed in partnership,with D.A.R.E., ... for the swift recovery of a missing ...
... A new study suggests that genetic factors influence ... which could in turn be partly responsible for increased ... size of the right orbitofrontal cortex (OFC), an area ... processing and impulsive behavior, is smaller in teenagers and ...
... to fulfill promise of a cure for his ... The Diabetes Research Institute,Foundation (DRIF) announced that ... president, effective November 17, and will be,responsible for ... Karlya is well-known in the diabetes community ...
... Holdings Corp. (Nasdaq:,HMSY) today announced that it will present ... be held November 12-14, 2008 at,the Arizona Biltmore Hotel ... Hosp, CFO, will present on Wednesday,November 12th at 11:00 ... ) is the nation,s leader in,coordination of benefits and ...
... Jersey,Hospital Association and the N.J. Department of Military ... dozen national organizations in a,sweeping effort to educate ... health-related problems faced by returning,veterans., Through the ... now receive training online on how to deal ...
Cached Medicine News:Health News:Free Web Site Lists Breast Cancer Clinical Trials 2Health News:Announcing Life-Prints: Child ID Software Medical Record Storage and More ... 2Health News:Impulse control area in brain affected in teens with genetic vulnerability for alcoholism 2Health News:'Diabetes Dad' Tom Karlya Rejoins Diabetes Research Institute Foundation 2Health News:'Diabetes Dad' Tom Karlya Rejoins Diabetes Research Institute Foundation 3Health News:N.J. Hospitals, Military and Veterans Affairs Join Broad Effort to Improve Returning Vets' Healthcare 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: